BBB Member

Bextra Withdrawal Could Be Just the Beginning for Pfizer


The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

©Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

CVS wants sick patients to keep taking medicine
Pittsburgh Post Gazette
There's nothing like a heart attack to convince someone to watch his or her diet, start exercising and take ...

and more »



Medicine Lodge teen killed, three others injured in wreck
Alva Review-Courier
Trista B. Herd, 16 of Medicine Lodge, Kan., died in a single vehicle crash that happened about 6:10 pm Tuesday. The accident occurred on ...
Medicine Lodge teen killed in auto accidentPratt Tribune

all 2 news articles »



The Star-Ledger - NJ.com

Johnson & Johnson Is Donating $200 Million In Cash, Medicine To A United ...
Comtex Smartrend
Johnson & Johnson (NYSE:JNJ) is donating $200 million in cash and medicine to a United Nations program that was created to improve the health ...
J&J giving $200 million for health of women, kidsThe Associated Press

all 176 news articles »


BG Medicine's Losses Mount As It Negotiates FDA Marketing Approval
Wall Street Journal
BG Medicine Inc. said its losses widened and its deficit grew in the first half as it continued negotiating regulatory approval for ...

and more »


FOXNews

Male Menopause: Reality or Myth?
FOXNews
Two papers published in the July issue of the New England Journal of Medicine addressed the diagnosis of hypogonadism and its treatment. ...
Male Menopause: Can Men Really Go Through the Change?Gossip On This (blog)

all 22 news articles »


St. Clair Record

Medical Malpractice Accounts for Less than 3% of US Health Costs: Study
AboutLawsuits.com
A new study has found that the combined costs of medical malpractice and so-called defensive medicine make up only 2.4% of the total costs of health care in ...
How Much Does Defensive Medicine Cost? One Study Says $46 BillionWall Street Journal (blog)
Costs Of Defensive Medicine May Be OverstatedNPR (blog)
Defensive medicine costs much less than 'imagined' by malpractice reformistsNews-Medical.net
FierceHealthcare -Medscape -BusinessWeek
all 101 news articles »


Scientific American (blog)

New MRI technique to identify kids with brain development problems
The Money Times
Researchers at the Washington University School of Medicine in St. Louis have devised a new kind of brain scan technique to help identify children whose ...
Brain Scans Could Spot Developmental Problems in KidsBusinessWeek
Prediction of Individual Brain Maturity Using fMRISecurities Industry News (blog) (subscription)
Mental maturity scan tracks brain developmentEurekAlert (press release)
LiveScience.com
all 42 news articles »


Argentina give Spain a taste of their own medicine
Telegraph.co.uk
Lionel Messi inspired Argentina to an emphatic 4-1 victory over world champions Spain in a friendly match in Buenos Aires, the first defeat suffered by the ...

and more »

Google News

home | site map
© 2006